| NCT ID | NCT07485829 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zimmer Biomet |
| Condition | Rib Fracture |
| Study Type | OBSERVATIONAL |
| Enrollment | 54 participants |
| Start Date | 2026-03-31 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 54 participants in total. It began in 2026-03-31 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective, single-center, non-randomized, single-cohort, post-market clinical follow-up study to confirm the safety, performance, and clinical benefits for the use of the RibFix Titan™ system implants and instrumentation) in the fusion, stabilization, and fixation of fractures in the chest wall including rib reconstructive surgical procedures, trauma, or planned osteotomies.
Eligibility Criteria
Inclusion Criteria: 1. At least 18 years of age 2. Willing and able to sign an Institutional Review Board (IRB) approved Informed Consent Form and able to comply with study requirements, in the Investigator's opinion 3. Independent of study participation, patient qualifies for fixation, stabilization, and/or fusion of rib fractures or osteotomies of normal and osteoporotic bone with the study device Exclusion Criteria: 1. Midline Sternotomy: sternotomy incisions crossing the midline 2. Active Infection: patients should not have any ongoing infections 3. Material Sensitivity: where sensitivity to materials is suspected, comprehensive testing should be conducted before implantation 4. Inability to Adhere to Post-operative Care: Patients must have the ability and willingness to comply with post-operative care instructions, which may not be possible for individuals with certain mental or neurological conditions 5. Patients not expected to survive the duration of follow-up due to the involvement of trauma situations 6. Patients with a history of alcohol or substance abuse, as well as vulnerable populations such as prisoners and pregnant women
Contact & Investigator
Hillary Overholser
STUDY DIRECTOR
Zimmer Biomet
Frequently Asked Questions
Who can join the NCT07485829 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Rib Fracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07485829 currently recruiting?
Yes, NCT07485829 is actively recruiting participants. Contact the research team at megan.mckinnie@zimmerbiomet.com for enrollment information.
Where is the NCT07485829 trial being conducted?
This trial is being conducted at Indianapolis, United States.
Who is sponsoring the NCT07485829 clinical trial?
NCT07485829 is sponsored by Zimmer Biomet. The principal investigator is Hillary Overholser at Zimmer Biomet. The trial plans to enroll 54 participants.